Occupational exposure to lead compounds and risk of cancer among men: A population-based case-control study

American Journal of Epidemiology

Volumn 166, Issue 9, 2007, Pages 1005-1014

  Rousseau, M C ^a   Parent, M E ^a   Nadon, L ^a   Latreille, B ^a   Siemiatycki, J ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Case control studies; Inorganic chemicals; Lead; Male; Neoplasms; Occupational exposure; Organic chemicals

Indexed keywords

GASOLINE; LEAD; ORGANOLEAD COMPOUND;

CANCER; CARCINOGEN; DISEASE INCIDENCE; EPIDEMIOLOGY; HEALTH RISK; INORGANIC MATTER; LEAD; MENS HEALTH; OCCUPATIONAL EXPOSURE; ORGANIC MATTER; REGRESSION ANALYSIS;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANADA; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; ESOPHAGUS CANCER; HUMAN; INTERVIEW; KIDNEY CANCER; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; MELANOMA; NONHODGKIN LYMPHOMA; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; PANCREAS CANCER; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; WORK;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DATA COLLECTION; HUMANS; INCIDENCE; LEAD; MALE; MIDDLE AGED; NEOPLASMS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; ODDS RATIO; QUEBEC; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

CANADA; MONTREAL; NORTH AMERICA; QUEBEC [CANADA];

EID: 35348883685     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm183     Document Type: Article

References (54)

1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 87. Inorganic and organic lead compounds. Lyon, France: International Agency for Research on Cancer, 2006.
2. International Lead and Zinc Study Group. End uses of lead and zinc. Lisbon, Portugal: International Lead and Zinc Study Group, 2007. (http://www.ilzsg.org/statistics.asp?pg=eco). (Last accessed July 23, 2007).
3. International Lead and Zinc Study Group. Lead statistics. Lisbon, Portugal: International Lead and Zinc Study Group, 2007. (http://www.ilzsg.org/ statistics.asp?pg=lead). (Last accessed July 23, 2007).
4. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man. Vol 1. Some inorganic substances, chlorinated hydrocarbons, aromatic amines, N-nitroso compounds, and natural products. Lyon, France: International Agency for Research on Cancer, 1972.
5. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man. Vol 2. Some inorganic and organometallic compounds. Lyon, France: International Agency for Research on Cancer, 1973.
6. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to man. Vol 12. Some carbamates, thiocarbamates and carbazides. Lyon, France: International Agency for Research on Cancer, 1976.
7. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol 23. Some metals and metallic compounds. Lyon, France: International Agency for Research on Cancer, 1980.
8. International Agency for Research on Cancer. Evaluation of the carcinogenic risk of chemicals to humans. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. Lyon, France: International Agency for Research on Cancer, 1987.
9. van Wijngaarden E, Dosemeci M. Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer 2006;119:1136-44.
10. Rajaraman P, Stewart PA, Samet JM, et al. Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 2006;15:2514-20.
11. Steenland K, Boffetta P. Lead and cancer in humans: where are we now? Am J Ind Med 2000;38:295-9.
12. Siemiatycki J. Risk factors for cancer in the workplace. Boca Raton, FL: CRC Press, 1991.
13. Siemiatycki J, Wacholder S, Richardson L, et al. Discovering carcinogens in the occupational environment: methods of data collection and analysis of a large case-referent monitoring system. Scand J Work Environ Health 1987;13:486-92.
14. Gérin M, Siemiatycki J, Kemper H, et al. Obtaining occupational exposure histories in epidemiologic case-control studies. J Occup Med 1985;27:420-6.
15. Parent ME, Rousseau MC, Boffetta P, et al. Exposure to diesel and gasoline engine emissions and the risk of lung cancer. Am J Epidemiol 2007;165:53-62.
16. Carre DJ, Bertrand PA, Lince JR. Lead naphthenate additive tribochemistry in hydrocarbon oils. (NASA technical report). Washington, DC: National Aeronautics and Space Administration, 2001.
17. Minister of Supply and Services Canada. Lead-free gasoline and nozzle control programs Quebec 1976 to 1981. (Surveillance report EPS 5-RQ-83-1 E). Montreal, Quebec, Canada: Environmental Protection Service, Environment Canada, 1983. (http://www.ec.gc.ca/).
18. United Nations Environment Programme and Organisation for Economic Co-operation and Development. Phasing lead out of gasoline: an examination of policy approaches in different countries. New York, NY: United Nations Environment Programme, 1999. (http://www.unep.fr/energy/act/tp/ldgas/index.htm).
19. Health Canada. Effects of lead on human health. In: It's your health. Ottawa, Ontario, Canada: Health Canada, 2004. (http://www.hc-sc.gc.ca/iyh-vsv/ alt_formats/cmcd-dcmc/pdf/lead_e.pdf).
20. National Toxicology Program, National Institute of Environmental Health Sciences. Report on carcinogens - background document for "lead and lead compounds." Research Triangle Park, NC: National Institute of Environmental Health Sciences, 2003. (http://ntp-server.niehs.nih.gov/ntp/newhomeroc/roc11/ Lead-Public.pdf).
21. Leffondré K, Abrahamowicz M, Siemiatycki J, et al. Modeling smoking history: a comparison of different approaches. Am J Epidemiol 2002;156:813-23.
22. Hartwig A. Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review. Environ Health Perspect 1994;102(suppl 3):45-50.
23. Hartwig A, Schlepegrell R, Beyersmann D. Indirect mechanism of lead-induced genotoxicity in cultured mammalian cells. Mutat Res 1990;241:75-82.
24. Popenoe EA, Schmaeler MA. Interaction of human DNA polymerase beta with ions of copper, lead, and cadmium. Arch Biochem Biophys 1979;196:109-20.
25. Frenkel GD, Middleton C. Effects of lead acetate on DNA and RNA synthesis by intact HeLa cells, isolated nuclei and purified polymerases. Biochem Pharmacol 1987;36:265-8.
26. Menegazzi M, Carcereri de Prati A, Ogura T, et al. Involvement of DNA polymerase beta in proliferation of rat liver induced by lead nitrate or partial hepatectomy. FEBS Lett 1992;310:135-8.
27. National Toxicology Program, National Institute of Environmental Health Sciences. 11th report on carcinogens. Research Triangle Park, NC: National Institute of Environmental Health Sciences, 2005. (http://ntp.niehs.nih.gov/go/ 16183).
28. Epstein SS, Mantel N. Carcinogenicity of tetraethyl lead. Experientia 1968;24:580-1.
29. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 87. Inorganic and organic lead compounds. Summary of data reported and evaluation. Lyon, France: International Agency for Research on Cancer, 2006. (http://monographs.iarc.fr/ENG/Monographs/ vol87/volume87.pdf).
30. Davies JM. Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Ind Med 1984;41:158-69.
31. Fu H, Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med 1995;52:73-81.
32. Gerhardsson L, Lundstrom NG, Nordberg G, et al. Mortality and lead exposure: a retrospective cohort study of Swedish smelter workers. Br J Ind Med 1986;43:707-12.
33. Ades AE, Kazantzis G. Lung cancer in a non-ferrous smelter: the role of cadmium. Br J Ind Med 1988;45:435-42.
34. Levin LI, Zheng W, Blot WJ, et al. Occupation and lung cancer in Shanghai: a case-control study. Br J Ind Med 1988;45:450-8.
35. Sankila R, Karjalainen S, Pukkala E, et al. Cancer risk among glass factory workers: an excess of lung cancer? Br J Ind Med 1990;47:815-18.
36. Wingren G, Axelson O. Epidemiologic studies of occupational cancer as related to complex mixtures of trace elements in the art glass industry. Scand J Work Environ Health 1993;19:95-100.
37. Anttila A, Heikkila P, Pukkala E, et al. Excess lung cancer among workers exposed to lead. Scand J Work Environ Health 1995;21:460-9.
38. Lundstrom NG, Nordberg G, Englyst V, et al. Cumulative lead exposure in relation to mortality and lung cancer morbidity in a cohort of primary smelter workers. Scand J Work Environ Health 1997;23:24-30.
39. Englyst V, Lundstrom NG, Gerhardsson L, et al. Lung cancer risks among lead smelter workers also exposed to arsenic. Sci Total Environ 2001;273:77-82.
40. Gerhardsson L, Hagmar L, Rylander L, et al. Mortality and cancer incidence among secondary lead smelter workers. Occup Environ Med 1995;52:667-72.
41. Wong O, Harris F. Cancer mortality study of employees at lead battery plants and lead smelters, 1947-1995. Am J Ind Med 2000;38:255-70.
42. Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers - an update. Am J Public Health 1992;82:1641-4.
43. Fayerweather WE, Karns ME, Nuwayhid IA, et al. Case-control study of cancer risk in tetraethyl lead manufacturing. Am J Ind Med 1997;31:28-35.
44. Sheffet A, Thind I, Miller AM, et al. Cancer mortality in a pigment plant utilizing lead and zinc chromates. Arch Environ Health 1982;37:44-52.
45. Lundstrom NW, Englyst V, Gerhardsson L, et al. Lung cancer development in primary smelter workers: a nested case-referent study. J Occup Environ Med 2006;48:376-80.
46. Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention. Lead toxicity. (Case studies in environmental medicine). Atlanta, GA: Agency for Toxic Substances and Disease Registry, 2000. (http://www.atsdr.cdc.gov/HEC/CSEM/lead/index.html).
47. US Environmental Protection Agency Persistent, Bioaccumulative, and Toxic Pollutants (PBT) Program. PBT national action plan for alkyl-lead. Washington, DC: Environmental Protection Agency, 2004. (http://www.epa.gov/pbt/pubs/ Alkyl_lead_action_plan_final.pdf).
48. Baumgarten M, Siemiatycki J, Gibbs GW. Validity of work histories obtained by interview for epidemiologic purposes. Am J Epidemiol 1983;118:583-91.
49. Goldberg MS, Siemiatycki J, Gérin M. Inter-rater agreement in assessing occupational exposure in a case-control study. Br J Ind Med 1986;43:667-76.
50. Siemiatycki J, Fritschi L, Nadon L, et al. Reliability of an expert rating procedure for retrospective assessment of occupational exposures in community-based case-control studies. Am J Ind Med 1997;31:280-6.
51. Fritschi L, Nadon L, Benke G, et al. Validation of expert assessment of occupational exposures. Am J Ind Med 2003;43:519-22.
52. Bouyer J, Hemon D. Studying the performance of a job exposure matrix. Int J Epidemiol 1993;22(suppl):S65-71.
53. Smith AH, Pearce NE, Callas PW. Cancer case-control studies with other cancers as controls. Int J Epidemiol 1988;17:298-306.
54. Parent ME, Siemiatycki J, Fritschi L. Occupational exposures and gastric cancer. Epidemiology 1998;9:48-55.